Whitehawk Therapeutics, Stock Market Value
| WHWK Stock | 2.72 0.07 2.64% |
| Symbol | Whitehawk |
Whitehawk Therapeutics, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Whitehawk Therapeutics,. If investors know Whitehawk will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Whitehawk Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.15 | Revenue Per Share | Quarterly Revenue Growth 0.335 | Return On Assets | Return On Equity |
The market value of Whitehawk Therapeutics, is measured differently than its book value, which is the value of Whitehawk that is recorded on the company's balance sheet. Investors also form their own opinion of Whitehawk Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Whitehawk Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Whitehawk Therapeutics,'s market value can be influenced by many factors that don't directly affect Whitehawk Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Whitehawk Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Whitehawk Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Whitehawk Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Whitehawk Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Whitehawk Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Whitehawk Therapeutics,.
| 11/24/2025 |
| 12/24/2025 |
If you would invest 0.00 in Whitehawk Therapeutics, on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Whitehawk Therapeutics, or generate 0.0% return on investment in Whitehawk Therapeutics, over 30 days. Whitehawk Therapeutics, is related to or competes with Citius Pharmaceuticals, Dare Bioscience, Longeveron LLC, FibroBiologics, Common, Athira Pharma, Pulmatrix, and Aditxt. Whitehawk Therapeutics, is entity of United States More
Whitehawk Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Whitehawk Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Whitehawk Therapeutics, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.61 | |||
| Information Ratio | 0.0817 | |||
| Maximum Drawdown | 39.61 | |||
| Value At Risk | (7.50) | |||
| Potential Upside | 9.69 |
Whitehawk Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Whitehawk Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Whitehawk Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Whitehawk Therapeutics, historical prices to predict the future Whitehawk Therapeutics,'s volatility.| Risk Adjusted Performance | 0.0737 | |||
| Jensen Alpha | 0.5004 | |||
| Total Risk Alpha | 0.0516 | |||
| Sortino Ratio | 0.0926 | |||
| Treynor Ratio | 0.4375 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Whitehawk Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Whitehawk Therapeutics, Backtested Returns
Whitehawk Therapeutics, appears to be dangerous, given 3 months investment horizon. Whitehawk Therapeutics, shows Sharpe Ratio of 0.12, which attests that the company had a 0.12 % return per unit of risk over the last 3 months. By examining Whitehawk Therapeutics,'s technical indicators, you can evaluate if the expected return of 0.77% is justified by implied risk. Please utilize Whitehawk Therapeutics,'s Mean Deviation of 4.34, market risk adjusted performance of 0.4475, and Downside Deviation of 5.61 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Whitehawk Therapeutics, holds a performance score of 9. The firm maintains a market beta of 1.32, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Whitehawk Therapeutics, will likely underperform. Please check Whitehawk Therapeutics,'s semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Whitehawk Therapeutics,'s historical returns will revert.
Auto-correlation | 0.26 |
Poor predictability
Whitehawk Therapeutics, has poor predictability. Overlapping area represents the amount of predictability between Whitehawk Therapeutics, time series from 24th of November 2025 to 9th of December 2025 and 9th of December 2025 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Whitehawk Therapeutics, price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Whitehawk Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Whitehawk Therapeutics, lagged returns against current returns
Autocorrelation, which is Whitehawk Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Whitehawk Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Whitehawk Therapeutics, returns to help us make a trade decision. For example, suppose you find that Whitehawk Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Whitehawk Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Whitehawk Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Whitehawk Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Whitehawk Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Whitehawk Therapeutics, Lagged Returns
When evaluating Whitehawk Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Whitehawk Therapeutics, stock have on its future price. Whitehawk Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Whitehawk Therapeutics, autocorrelation shows the relationship between Whitehawk Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Whitehawk Therapeutics,.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Whitehawk Therapeutics, Correlation, Whitehawk Therapeutics, Volatility and Whitehawk Therapeutics, Alpha and Beta module to complement your research on Whitehawk Therapeutics,. For more information on how to buy Whitehawk Stock please use our How to buy in Whitehawk Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Whitehawk Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.